+ Follow NORTH AMERICAN ASSOCIATION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 147975
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[1] => Array
(
[ArticleID] => 147165
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[2] => Array
(
[ArticleID] => 146356
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 145606
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 145289
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2001-12-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
NORTH AMERICAN ASSOCIATION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 147975
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[1] => Array
(
[ArticleID] => 147165
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[2] => Array
(
[ArticleID] => 146356
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 145606
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2002-01-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 145289
[Title] => Medicalines: New Data Proves Weight Loss Drus Claims
[Summary] => In the preliminary results of the new research conducted by the North American Association for the Study of Obesity (NSAASO), weight loss medication Xenical (Orlistat) helps overweight and obese people lose weight rapidly and is associated with rapid improvements in cardiovascular risk factors.
[DatePublished] => 2001-12-29 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
January 22, 2002 - 12:00am
January 15, 2002 - 12:00am
January 8, 2002 - 12:00am
January 1, 2002 - 12:00am
December 29, 2001 - 12:00am